Literature DB >> 11751711

Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study.

T Asai1, T Ohkubo, T Katsuya, J Higaki, Y Fu, M Fukuda, A Hozawa, M Matsubara, H Kitaoka, I Tsuji, T Araki, H Satoh, S Hisamichi, Y Imai, T Ogihara.   

Abstract

A recent report based on the results of 2 epidemiological studies, the Etude Cas-Temoin de l'Infarctus Myocarde (ECTIM) and the Glasgow Heart Scan Study, revealed that a G/T polymorphism with an amino acid substitution (Lys-->Asn) at codon 198 in exon 5 of the endothelin-1 gene (ET-1) is associated with blood pressure in overweight people. They suggested that G/T polymorphism of ET-1 strongly interacted with body mass index (BMI) in the determination of BP levels. To examine interaction among G/T polymorphism of ET-1, BMI, and BP, we performed an association study in a general Japanese population. Subjects (n=1250) were recruited from Ohasama, a cohort in a rural community of northern Japan. DNA was extracted from buffy coat of participants, and G/T polymorphism of ET-1 was determined by the TaqMan probe polymerase chain reaction method, a powerful tool for semiautomatic genotype determination of a large number of samples. Frequency of T (Asn 198) allele in Japanese (27%) was slightly but significantly higher than in whites (24%). Baseline characteristics (age, BMI, systolic and diastolic BP, and antihypertensive treatment) of all subjects were not significantly different according to the genotype of G/T polymorphism. However, in obese subjects (> or =25 kg/m(2)) diastolic BPs were significantly associated with G/T polymorphism of ET-1. After adjustment for confounding factors, significant association remained; for overweight subjects, diastolic BP level in those with T allele (GT + TT) was 1.8 mm Hg (P=0.04) higher than in those with GG genotype. That similar results were obtained from subjects of different races suggests that the Lys198Asn polymorphism of ET-1 is involved in determination of BP levels in obese subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751711     DOI: 10.1161/hy1101.095333

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  30 in total

1.  Interactive influences of ethnicity, endothelin-1 gene, and everyday discrimination upon nocturnal ambulatory blood pressure.

Authors:  Mathew J Gregoski; Sarah G Buxbaum; Gaston Kapuku; Yanbin Dong; Haidong Zhu; Mary Davis; Kelsey Gonto; Frank A Treiber
Journal:  Ann Behav Med       Date:  2013-06

Review 2.  ET-1 actions in the kidney: evidence for sex differences.

Authors:  W Kittikulsuth; J C Sullivan; D M Pollock
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

3.  Enhanced endothelin-1 system activity with overweight and obesity.

Authors:  Brian R Weil; Christian M Westby; Gary P Van Guilder; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

4.  Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol.

Authors:  Guillaume Pare; David Serre; Diane Brisson; Sonia S Anand; Alexandre Montpetit; Gerald Tremblay; James C Engert; Thomas J Hudson; Daniel Gaudet
Journal:  Am J Hum Genet       Date:  2007-02-21       Impact factor: 11.025

5.  Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Authors:  Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams
Journal:  JCI Insight       Date:  2017-12-07

6.  Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease.

Authors:  Steven Wiltshire; Brenda L Powell; Michelle Jennens; Pamela A McCaskie; Kim W Carter; Lyle J Palmer; Peter L Thompson; Brendan M McQuillan; Joseph Hung; John P Beilby
Journal:  Hum Genet       Date:  2008-02-21       Impact factor: 4.132

7.  Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study.

Authors:  Ken Sugimoto; Tomohiro Katsuya; Kei Kamide; Tomomi Fujisawa; Izumi Shimaoka; Mitsuru Ohishi; Ryuichi Morishita; Toshio Ogihara; Hiromi Rakugi
Journal:  Int J Hypertens       Date:  2010-08-24       Impact factor: 2.420

Review 8.  Endothelin-1 and hypertension: from bench to bedside.

Authors:  Donald E Kohan
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

9.  Genotype-phenotype associations: modulation by diet and obesity.

Authors:  Jose M Ordovas
Journal:  Obesity (Silver Spring)       Date:  2008-12       Impact factor: 5.002

Review 10.  The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis.

Authors:  Dolores Corella; Jose M Ordovas
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.